# Phase 1 Study of TAK-831 in Healthy Adult Asian Subjects

> **NCT03687684** · PHASE1 · COMPLETED · sponsor: **Neurocrine Biosciences** · enrollment: 40 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** TAK-831
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03687684
- **Lead sponsor:** Neurocrine Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-09
- **Primary completion:** 2019-06-09
- **Final completion:** 2019-06-19
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03687684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03687684, "Phase 1 Study of TAK-831 in Healthy Adult Asian Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03687684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*